公司新闻
更多>>公司公告
更多>>- 10/15FUSION ANTIBODIES PLC--Result of AGM
- 10/15FUSION ANTIBODIES PLC--AGM statement H1 trading and research update
- 10/05FUSION ANTIBODIES PLC--Launch of new customer-focused website
- 09/22FUSION ANTIBODIES PLC--Posting of Annual Report & Notice of AGM
- 09/15FUSION ANTIBODIES PLC--REPLACEMENT: Final Results
- 09/14FUSION ANTIBODIES PLC--Final Results
- 09/09FUSION ANTIBODIES PLC--Notice of Results
- 09/09FUSION ANTIBODIES PLC--Grant of Canadian Patent for OptiMAL
- 08/06FUSION ANTIBODIES PLC--Notice of acceptance of patent in Australia
- 07/20FUSION ANTIBODIES PLC--Grant of options
- 07/01FUSION ANTIBODIES PLC--Holding(s) in Company
- 06/30FUSION ANTIBODIES PLC--Total Voting Rights
- 06/22FUSION ANTIBODIES PLC--Notice of allowance of patent in Canada
- 06/15FUSION ANTIBODIES PLC--Update on grant-funded DR5 project